What's coming? Pazdur, Marks and Woodcock discuss FDA changes
Three of the FDA’s directors — Richard Pazdur, Peter Marks and Janet Woodcock — took the stage Wednesday at Prevision Policy’s Biopharma Congress to discuss all things …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.